Elizabeth Bondi, Martin Ringeisen, Lennart Gerdesmeyer
{"title":"Bone marrow edema of the femoral head treated with extracorporeal magnetotransduction therapy and conservative management: a case series.","authors":"Elizabeth Bondi, Martin Ringeisen, Lennart Gerdesmeyer","doi":"10.1186/s13256-026-06661-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Bone marrow edema of the hip is a painful condition that can significantly impair function and may lead to more serious joint problems if left untreated. Extracorporeal magnetotransduction therapy (EMTT) is an innovative non-invasive treatment that shows promise in orthopedic applications. However, its use has not been documented for treating bone marrow edema. This case series describes two patients with femoral head bone marrow edema in whom clinical symptoms and radiological findings improved following EMTT given alongside conservative treatment.</p><p><strong>Case presentations: </strong>We report on two German male patients, aged 44 and 55, who presented with an acute onset of hip pain lasting four weeks, with no history of trauma. Both patients exhibited reduced hip mobility, and magnetic resonance imaging (MRI) scans confirmed bone marrow edema in the femoral head. Each patient underwent eight sessions of EMTT over four weeks (10,000 pulses, 8 Hz, intensity level 8), alongside standard conservative treatments, which included medication, physiotherapy and, in one patient, partial off-loading. At follow-up appointments (13 weeks and 9 weeks post-consultation, respectively), both patients reported complete pain relief and regained their range of motion. MRI results confirmed near-complete resolution of the edema in both cases.</p><p><strong>Conclusion: </strong>In both patients, symptoms and MRI findings improved following EMTT administered together with conservative treatment, and the treatment was well tolerated. Considering the small number of patients, the concurrent interventions and the self-limiting natural history of bone marrow edema, a causal contribution of EMTT cannot be established from these observations. The favorable course nevertheless supports the formal evaluation of EMTT in this indication, and randomized controlled trials are needed to determine its efficacy in bone marrow edema.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"20 1","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13654217/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13256-026-06661-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Bone marrow edema of the hip is a painful condition that can significantly impair function and may lead to more serious joint problems if left untreated. Extracorporeal magnetotransduction therapy (EMTT) is an innovative non-invasive treatment that shows promise in orthopedic applications. However, its use has not been documented for treating bone marrow edema. This case series describes two patients with femoral head bone marrow edema in whom clinical symptoms and radiological findings improved following EMTT given alongside conservative treatment.
Case presentations: We report on two German male patients, aged 44 and 55, who presented with an acute onset of hip pain lasting four weeks, with no history of trauma. Both patients exhibited reduced hip mobility, and magnetic resonance imaging (MRI) scans confirmed bone marrow edema in the femoral head. Each patient underwent eight sessions of EMTT over four weeks (10,000 pulses, 8 Hz, intensity level 8), alongside standard conservative treatments, which included medication, physiotherapy and, in one patient, partial off-loading. At follow-up appointments (13 weeks and 9 weeks post-consultation, respectively), both patients reported complete pain relief and regained their range of motion. MRI results confirmed near-complete resolution of the edema in both cases.
Conclusion: In both patients, symptoms and MRI findings improved following EMTT administered together with conservative treatment, and the treatment was well tolerated. Considering the small number of patients, the concurrent interventions and the self-limiting natural history of bone marrow edema, a causal contribution of EMTT cannot be established from these observations. The favorable course nevertheless supports the formal evaluation of EMTT in this indication, and randomized controlled trials are needed to determine its efficacy in bone marrow edema.
期刊介绍:
JMCR is an open access, peer-reviewed online journal that will consider any original case report that expands the field of general medical knowledge. Reports should show one of the following: 1. Unreported or unusual side effects or adverse interactions involving medications 2. Unexpected or unusual presentations of a disease 3. New associations or variations in disease processes 4. Presentations, diagnoses and/or management of new and emerging diseases 5. An unexpected association between diseases or symptoms 6. An unexpected event in the course of observing or treating a patient 7. Findings that shed new light on the possible pathogenesis of a disease or an adverse effect